Related references
Note: Only part of the references are listed.Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI)
Thomas M. Atkinson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
Psychometric Evaluation of the Arabic Brief Pain Inventory in a Sample of Lebanese Cancer Patients
Suha Ballout et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
The Brief Pain Inventory and Its Pain At Its Worst in the Last 24 Hours Item: Clinical Trial Endpoint Considerations
Thomas M. Atkinson et al.
PAIN MEDICINE (2010)
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Russian brief pain inventory: Validation and application in cancer pain
Svetlana A. Kalyadina et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
Validation of the Brief Pain Inventory in patients six months after cardiac surgery
Kari Hanne Gjeilo et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
The reliability and validity of pain interference measures in persons with multiple sclerosis
Travis L. Osborne et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis
T Mendoza et al.
EUROPEAN JOURNAL OF PAIN (2006)
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480
Peter A. Humphrey et al.
CLINICAL GENITOURINARY CANCER (2006)
The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain
VSL Williams et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Prognostic significance of plasma chromogranin A levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
ME Taplin et al.
UROLOGY (2005)
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480
DJ George et al.
CLINICAL CANCER RESEARCH (2005)
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
RH Dworkin et al.
PAIN (2005)
Validation of the brief pain inventory for chronic nonmalignant pain
G Tan et al.
JOURNAL OF PAIN (2004)
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain
S Keller et al.
CLINICAL JOURNAL OF PAIN (2004)
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma - Results of Intergroup 0159/Cancer and Leukemia Group B 9480
TA Ahles et al.
CANCER (2004)
Development of a cancer pain assessment tool in Korea: A validation study of a Korean version of the Brief Pain Inventory
YH Yun et al.
ONCOLOGY (2004)
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: A nested study within CALGB 9583
S Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The Norwegian Brief Pain Inventory questionnaire: Translation and validation in cancer pain patients
P Klepstad et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: Results of intergroup 0159, cancer and leukemia group B 9480
EJ Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Greek Brief Pain Inventory: Validation and utility in cancer pain
K Mystakidou et al.
ONCOLOGY (2001)
Share Paper
